In line with our findings, previous studies have shown that SRSF1 was increased in gliomas, which promoted gliomagenesis via guided alternative splicing of the MYO1B gene, leading to activation of PDK1/AKT and PAK/LIMK signaling pathways 39. Here, SRSF1 is linked to central nervous system cancer.